| Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer ET Morgan, KB Goralski, M Piquette-Miller, KW Renton, GR Robertson, ... Drug Metabolism and Disposition 36 (2), 205-216, 2008 | 457 | 2008 |
| Inflammatory cytokines, but not bile acids, regulate expression of murine hepatic anion transporters in endotoxemia G Hartmann, AKY Cheung, M Piquette-Miller Journal of Pharmacology and Experimental Therapeutics 303 (1), 273-281, 2002 | 269 | 2002 |
| Polymeric drug delivery systems for localized cancer chemotherapy R De Souza, P Zahedi, CJ Allen, M Piquette-Miller Drug delivery 17 (6), 365-375, 2010 | 224 | 2010 |
| The involvement of the pregnane X receptor in hepatic gene regulation during inflammation in mice S Teng, M Piquette-Miller Journal of Pharmacology and Experimental Therapeutics 312 (2), 841-848, 2005 | 209 | 2005 |
| Regulation of the multidrug resistance genes by stress signals M Sukhai, M Piquette-Miller J Pharm Pharm Sci 3 (2), 268-280, 2000 | 203 | 2000 |
| Regulation of drug transporters: during infection and inflammation V Petrovic, S Teng, M Piquette-Miller Molecular interventions 7 (2), 99, 2007 | 199 | 2007 |
| Synthesis and physicochemical and dynamic mechanical properties of a water-soluble chitosan derivative as a biomaterial J Cho, J Grant, M Piquette-Miller, C Allen Biomacromolecules 7 (10), 2845-2855, 2006 | 197 | 2006 |
| Regulation of the hepatic multidrug resistance gene expression by endotoxin and inflammatory cytokines in mice G Hartmann, H Kim, M Piquette-Miller International immunopharmacology 1 (2), 189-199, 2001 | 196 | 2001 |
| Induction of ABCC3 (MRP3) by pregnane X receptor activators S Teng, V Jekerle, M Piquette-Miller Drug Metabolism and Disposition 31 (11), 1296-1299, 2003 | 183 | 2003 |
| Decreased expression and activity of P-GIycoprotein in rat liver during acute inflammation M Piquette-Miller, A Pak, H Kim, R Anari, A Shahzamani Pharmaceutical research 15, 706-711, 1998 | 179 | 1998 |
| Transport of glyburide by placental ABC transporters: implications in fetal drug exposure C Gedeon, J Behravan, G Koren, M Piquette-Miller Placenta 27 (11-12), 1096-1102, 2006 | 174 | 2006 |
| Downregulation of mdr1a expression in the brain and liver during CNS inflammation alters the in vivo disposition of digoxin KB Goralski, G Hartmann, M Piquette‐Miller, KW Renton British journal of pharmacology 139 (1), 35-48, 2003 | 164 | 2003 |
| Hepatoprotective role of PXR activation and MRP3 in cholic acid‐induced cholestasis S Teng, M Piquette‐Miller British journal of pharmacology 151 (3), 367-376, 2007 | 158 | 2007 |
| Suppression of drug-metabolizing enzymes and efflux transporters in the intestine of endotoxin-treated rats J Kalitsky-Szirtes, A Shayeganpour, DR Brocks, M Piquette-Miller Drug Metabolism and Disposition 32 (1), 20-27, 2004 | 157 | 2004 |
| Ethnic differences in drug metabolism and toxicity from chemotherapy VH Phan, MM Moore, AJ McLachlan, M Piquette-Miller, H Xu, SJ Clarke Expert opinion on drug metabolism & toxicology 5 (3), 243-257, 2009 | 141 | 2009 |
| Decreased expression of P-glycoprotein in interleukin-1β and interleukin-6 treated rat hepatocytes M Sukhai, A Yong, A Pak, M Piquette-Miller Inflammation Research 50, 362-370, 2001 | 136 | 2001 |
| Functional and molecular characteristics of Na+-dependent nucleoside transporters J Wang, ME Schaner, S Thomassen, SF Su, M Piquette-Miller, ... Pharmaceutical research 14, 1524-1532, 1997 | 132 | 1997 |
| Inflammation-mediated changes in drug transporter expression/activity: implications for therapeutic drug response AM Cressman, V Petrovic, M Piquette-Miller Expert review of clinical pharmacology 5 (1), 69-89, 2012 | 130 | 2012 |
| Research directions in the clinical implementation of pharmacogenomics: an overview of US programs and projects S Volpi, CJ Bult, RL Chisholm, PA Deverka, GS Ginsburg, HJ Jacob, ... Clinical Pharmacology & Therapeutics 103 (5), 778-786, 2018 | 129 | 2018 |
| Influence of IL-6 on MDR and MRP-mediated multidrug resistance in human hepatoma cells G Lee, M Piquette-Miller Canadian journal of physiology and pharmacology 79 (10), 876-884, 2001 | 121 | 2001 |
